Treatment Gaps Linked to Worse Long-Term Vision Outcomes in Wet AMD

At ARVO 2026, Andrew A. Moshfeghi, MD, MBA, FASRS, presented a retrospective analysis of the Vestrum Health database examining treatment interruptions in neovascular AMD.

Andrew A. Moshfeghi, MD

Retinal Physician May 8, 2026

Andrew A. Moshfeghi, MD

Specialties: Retina; neovascular age-related macular degeneration

Bio: Andrew A. Moshfeghi, MD, MBA, FASRS, presented at the 2026 ARVO annual meeting on treatment interruptions in neovascular age-related macular degeneration. His reported work examined a retrospective Vestrum Health database analysis evaluating how treatment frequency and treatment gaps in intravitreal anti-VEGF therapy affected long-term visual outcomes in treatment-naïve wet AMD patients.

PentaVision

Retinal Physician

Treatment Gaps Linked to Worse Long-Term Vision Outcomes in Wet AMD

Recommendations